Literature DB >> 21434974

Denosumab.

Eline A Dubois1, Robert Rissmann, Adam F Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21434974      PMCID: PMC3099366          DOI: 10.1111/j.1365-2125.2011.03969.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Denosumab.

Authors:  René Rizzoli; Uma Yasothan; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

2.  Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Javier San Martin; Michael R McClung; Ethel S Siris; Richard Eastell; Ian R Reid; Pierre Delmas; Holly B Zoog; Matt Austin; Andrea Wang; Stepan Kutilek; Silvano Adami; Jose Zanchetta; Cesar Libanati; Suresh Siddhanti; Claus Christiansen
Journal:  N Engl J Med       Date:  2009-08-11       Impact factor: 91.245

  2 in total
  6 in total

1.  Denosumab: a case of MRONJ with resolution.

Authors:  C V Lyttle; H Patterson
Journal:  Br Dent J       Date:  2016-06-24       Impact factor: 1.626

2.  Etiologic Role of Kinases in the Progression of Human Cancers and Its Targeting Strategies.

Authors:  Sanjoy Das; Bireswar Bhattacharya; Biplajit Das; Bibek Sinha; Taison Jamatia; Kishan Paul
Journal:  Indian J Surg Oncol       Date:  2019-08-19

3.  Osteoclast Differentiation is Downregulated by Select Polyphenolic Fractions from Dried Plum via Suppression of MAPKs and Nfatc1 in Mouse C57BL/6 Primary Bone Marrow Cells.

Authors:  Jennifer L Graef; Elizabeth Rendina-Ruedy; Erica K Crockett; Ping Ouyang; Lei Wu; Jarrod B King; Robert H Cichewicz; Dingbo Lin; Edralin A Lucas; Brenda J Smith
Journal:  Curr Dev Nutr       Date:  2017-09-06

Review 4.  Osteoporosis: Current Concepts.

Authors:  Ibrahim Akkawi; Hassan Zmerly
Journal:  Joints       Date:  2018-06-14

5.  Mechanisms of acute hypercalcemia in pediatric patients following the interruption of Denosumab.

Authors:  A Deodati; D Fintini; E Levtchenko; M Rossi; G Ubertini; H Segers; G Battafarano; M Cappa; A Del Fattore
Journal:  J Endocrinol Invest       Date:  2021-07-03       Impact factor: 4.256

6.  Ten-Year Simulation of the Effects of Denosumab on Bone Remodeling in Human Biopsies.

Authors:  Duncan C Tourolle; David W Dempster; Charles Ledoux; Daniele Boaretti; Mauricio Aguilera; Najma Saleem; Ralph Müller
Journal:  JBMR Plus       Date:  2021-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.